VISTAGEN THERAPEUTICS INC (VTGN) Institutional Ownership Changes & 13F Activity

VISTAGEN THERAPEUTICS INC (VTGN). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Commodore Capital Lp, Renaissance Technologies LLC, Adar1 Capital Management, Llc, Two Sigma Investments, Lp, and Group One Trading Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Citadel Advisors LlcBuy+68,83968,839$15.56KQ2 2026Sep 02, 2026
Commodore Capital LpBuy+2,788,6202,788,620$630.23KQ2 2026Aug 14, 2026
Adar1 Capital Management, LlcSell-400,000-53.3%351,141$79.36KQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+378,373+80.6%847,992$191.65KQ2 2026Aug 14, 2026
Group One Trading LlcBuy+284,510+1431.5%304,385$68.79KQ2 2026Aug 14, 2026
Verdad Advisers, LpBuy+108,405+58.6%293,343$66.30KQ2 2026Aug 14, 2026
Jane Street Group, LlcSell-107,984-39.6%164,827$37.25KQ2 2026Aug 14, 2026
Osaic Holdings, Inc.Buy+39,755+961.9%43,888$10.08KQ2 2026Aug 14, 2026
Xtx Topco LtdSell-34,469-22.6%118,380$26.75KQ2 2026Aug 14, 2026
Scientech Research LlcBuy+30,28330,283$6.84KQ2 2026Aug 14, 2026
Bank Of America CorpBuy+16,57016,570$3.75KQ2 2026Aug 14, 2026
Luminus Management LlcBuy+7,062+1.8%403,115$91.10KQ2 2026Aug 14, 2026
Royal Bank Of CanadaSell-1,627-76.5%500$0.00Q2 2026Aug 14, 2026
Raymond James Financial IncSell-33-0.2%14,851$3.36KQ2 2026Aug 14, 2026
Renaissance Technologies LLCBuy+439,200+150.8%730,500$165.09KQ2 2026Aug 13, 2026
Acadian Asset Management LlcBuy+204,916+34.8%794,579$178.00KQ2 2026Aug 13, 2026
Virtu Financial LlcBuy+66,02166,021$15.00KQ2 2026Aug 13, 2026
Ubs Group AgSell-20,906-26.6%57,830$13.07KQ2 2026Aug 13, 2026
Northern Trust CorpBuy+8,168+11.2%80,823$18.27KQ2 2026Aug 13, 2026
Morgan StanleyBuy+297+29700.0%298$67.00Q2 2026Aug 13, 2026
Bnp Paribas Financial MarketsSell-7-53.8%6$1.00Q2 2026Aug 13, 2026
Geode Capital Management, LlcSell-88,389-19.5%365,002$82.51KQ2 2026Aug 12, 2026
Simplex Trading, LlcSell-75,354-84.1%14,295$3.23KQ2 2026Aug 12, 2026
Stonex Group Inc.Sell-4,358-28.7%10,840$6.62KQ2 2026Aug 12, 2026
Truvestments Capital LlcSell-1,452-8.5%15,540$3.51KQ2 2026Aug 12, 2026
Jpmorgan Chase & CoBuy+8282$62.00Q2 2026Aug 12, 2026
Advisorshares Investments LlcBuy+161,533+58.3%438,643$99.13KQ2 2026Aug 11, 2026
Tower Research Capital Llc (Trc)Buy+16,564+1053.7%18,136$4.10KQ2 2026Aug 11, 2026
Blackrock, Inc.Sell-103,075-23.0%345,432$78.07KQ2 2026Aug 07, 2026
Deutsche Bank Ag\Buy+12,00012,000$2.76KQ2 2026Aug 07, 2026
Showing 30 of 56

Frequently asked questions about VTGN activity

  • Which institutional owners are buying VTGN?

    Institutional owners buying VTGN include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in VTGN activity?

    "Buy" means an investor increased their reported position in VTGN compared to the prior reporting period. This reflects growing exposure to VISTAGEN THERAPEUTICS INC (VTGN) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in VTGN increasing?

    Institutional interest in VTGN can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.